Loading grant details…
Completed
PROGRAMMES
Swiss National Science Foundation
Translating a novel radioimmunotherapy into a safe and effective treatment for lymphoma
$12.86M
CHF
| Funder | Swiss National Science Foundation |
|---|---|
| Recipient Organization | Eth Zurich – Ethz |
| Country | Switzerland |
| Start Date | Oct 01, 2024 |
| End Date | Sep 30, 2025 |
| Duration | 364 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swiss National Science Foundation |
| Grant ID | 40B1-0_229790 |
Grant Description
Radioimmunotherapy
All Grantees
Eth Zurich – Ethz
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2024
End Year
2025
Grantees
1
Related Grants
Advertisement
